Page last updated: 2024-08-23

tetradecanoylphorbol acetate and cilnidipine

tetradecanoylphorbol acetate has been researched along with cilnidipine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, N; Hu, WY; Kanmatsuse, K; Su, JZ1
Conrad, H; Essin, K; Gollasch, M; Haller, H; Hofmann, F; Huang, Y; Kirsch, T; Klugbauer, N; Litteral, J; Löhn, M; Luft, FC; Muzzulini, U; Tsang, SY; Waldron, P1

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and cilnidipine

ArticleYear
Effects of the L- and N-type calcium channel blocker cilnidipine on growth of vascular smooth muscle cells from spontaneously hypertensive rats.
    Journal of cardiovascular pharmacology, 2001, Volume: 38, Issue:3

    Topics: Animals; Calcium Channel Blockers; Cell Division; Cells, Cultured; Culture Media, Serum-Free; Dihydropyridines; DNA; Fibroblast Growth Factor 2; Muscle, Smooth, Vascular; Nifedipine; Platelet-Derived Growth Factor; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Transforming Growth Factor beta1

2001
Cilnidipine is a novel slow-acting blocker of vascular L-type calcium channels that does not target protein kinase C.
    Journal of hypertension, 2002, Volume: 20, Issue:5

    Topics: Animals; Aorta; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Dihydropyridines; Electric Conductivity; Electrophysiology; Protein Isoforms; Protein Kinase C; Rats; Tetradecanoylphorbol Acetate; Vasoconstriction

2002